A Community-based Intervention Among Active Drug Users in Montpellier

NACompletedINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
Drug UseHCV Infection
Interventions
DIAGNOSTIC_TEST

HCV screening

All patients will have HCV screening using rapid tests. HIV and HBV testing will also be conducted and patients will be appropriately referred to appropriate health services.

DIAGNOSTIC_TEST

Diagnosis of hepatitis C

HCV-RNA assay (GeneXpert, Cepheid) will be performed for all participants with positive HCV serology to determine if patients have chronic hepatitis C (defined by HCV-RNA\>10 UI/mL). In addition a measure of the liver stiffness will be performed.

DRUG

HCV treatment

Direct-Acting Antiviral drugs will be prescribed for 8 or 12 weeks according to liver assessment.

Trial Locations (1)

34394

CHU Montpellier, Montpellier

All Listed Sponsors
lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT04008927 - A Community-based Intervention Among Active Drug Users in Montpellier | Biotech Hunter | Biotech Hunter